Literature DB >> 12162437

Cytokine polymorphisms in silicosis and other pneumoconioses.

Berran Yucesoy1, Val Vallyathan, Douglas P Landsittel, Petia Simeonova, Michael I Luster.   

Abstract

Silicosis and coal workers' pneumoconiosis are complex multifactorial lung diseases whose etiopathogenesis are not well defined. It is generally accepted that fibrotic lung disorders are mediated by macrophage-derived cytokines and growth factors. There is evidence showing a crucial role for tumor necrosis factor-a (TNF-alpha) and interleukin-1 (IL-1) in inflammation caused by silica dust and in the transition from simple to progressive massive fibrosis. In this review we discuss genetic polymorphisms responsible for regulating the production of these proinflammatory cytokines and their role in modifying silicosis severity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12162437

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  53 in total

Review 1.  Lung inflammation and fibrosis.

Authors:  P A Ward; G W Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

2.  The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.

Authors:  K M Kroeger; K S Carville; L J Abraham
Journal:  Mol Immunol       Date:  1997-04       Impact factor: 4.407

3.  Persistent overexpression of interleukin-1beta and tumor necrosis factor-alpha in murine silicosis.

Authors:  G S Davis; L M Pfeiffer; D R Hemenway
Journal:  J Environ Pathol Toxicol Oncol       Date:  1998       Impact factor: 3.567

4.  Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis.

Authors:  P F Piguet; M A Collart; G E Grau; A P Sappino; P Vassalli
Journal:  Nature       Date:  1990-03-15       Impact factor: 49.962

5.  Immunocytochemical characterization of lung macrophage surface phenotypes and expression of cytokines in acute experimental silicosis in mice.

Authors:  C Orfila; J C Lepert; S Gossart; M F Frisach; C Cambon; B Pipy
Journal:  Histochem J       Date:  1998-12

6.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.

Authors:  J A Schmidt; C N Oliver; J L Lepe-Zuniga; I Green; I Gery
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

7.  Systemic macrophage stimulation in rats with silicosis: enhanced release of tumor necrosis factor-alpha from alveolar and peritoneal macrophages.

Authors:  C Mohr; D Gemsa; C Graebner; D R Hemenway; K O Leslie; P M Absher; G S Davis
Journal:  Am J Respir Cell Mol Biol       Date:  1991-10       Impact factor: 6.914

8.  Abnormal secretion of interleukin-1 and tumor necrosis factor alpha by alveolar macrophages in coal worker's pneumoconiosis: comparison between simple pneumoconiosis and progressive massive fibrosis.

Authors:  P Lassalle; P Gosset; C Aerts; E Fournier; J J Lafitte; J M Degreef; B Wallaert; A B Tonnel; C Voisin
Journal:  Exp Lung Res       Date:  1990-01       Impact factor: 2.459

9.  Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene.

Authors:  J K Tarlow; F E Clay; M J Cork; A I Blakemore; A J McDonagh; A G Messenger; G W Duff
Journal:  J Invest Dermatol       Date:  1994-09       Impact factor: 8.551

10.  An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.

Authors:  A G Wilson; N de Vries; F Pociot; F S di Giovine; L B van der Putte; G W Duff
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  16 in total

1.  T-889C IL-1alpha promoter polymorphism influences the response to oral cyclophosphamide in scleroderma patients with alveolitis.

Authors:  Lorenzo Beretta; Francesca Cappiello; Morena Barili; Francesca Bertolotti; Raffaella Scorza
Journal:  Clin Rheumatol       Date:  2006-04-25       Impact factor: 2.980

2.  Molecular Evaluation of the IFN γ +874, TNF α -308, and IL-1Ra VNTR Sequences in Silicosis.

Authors:  Isa Abdi Rad; Iraj Mohebbi; Morteza Bagheri
Journal:  Maedica (Buchar)       Date:  2012-01

Review 3.  Pesticides, chemical and industrial exposures in relation to systemic lupus erythematosus.

Authors:  C G Parks; A J De Roos
Journal:  Lupus       Date:  2014-05       Impact factor: 2.911

Review 4.  Gene-environment interaction from international cohorts: impact on development and evolution of occupational and environmental lung and airway disease.

Authors:  Adam Gaffney; David C Christiani
Journal:  Semin Respir Crit Care Med       Date:  2015-05-29       Impact factor: 3.119

5.  Induction of chemokines by low-dose intratracheal silica is reduced in TNFR I (p55) null mice.

Authors:  Gloria S Pryhuber; Heidie L Huyck; Raymond Baggs; Günter Oberdörster; Jacob N Finkelstein
Journal:  Toxicol Sci       Date:  2003-03       Impact factor: 4.849

6.  Autoantibodies in silicosis patients and in silica-exposed individuals.

Authors:  Gabriel Zaghi; Fábio Koga; Renato M Nisihara; Thelma L Skare; Antonieta Handar; Shirley R Rosa Utiyama; Marilia Barreto Silva
Journal:  Rheumatol Int       Date:  2009-08-25       Impact factor: 2.631

Review 7.  Silica binding and toxicity in alveolar macrophages.

Authors:  Raymond F Hamilton; Sheetal A Thakur; Andrij Holian
Journal:  Free Radic Biol Med       Date:  2007-12-27       Impact factor: 7.376

Review 8.  Dust events, pulmonary diseases and immune system.

Authors:  Nafiseh Esmaeil; Marjan Gharagozloo; Abbas Rezaei; Gabriele Grunig
Journal:  Am J Clin Exp Immunol       Date:  2014-02-27

9.  Gene-environment interactions in the development of complex disease phenotypes.

Authors:  Rosemarie G Ramos; Kenneth Olden
Journal:  Int J Environ Res Public Health       Date:  2008-03       Impact factor: 3.390

10.  Polymorphism in clinical immunology - From HLA typing to immunogenetic profiling.

Authors:  Ping Jin; Ena Wang
Journal:  J Transl Med       Date:  2003-11-18       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.